India  

FDA panel endorses booster shot for J&J Covid-19 vaccine

IndiaTimes Saturday, 16 October 2021
US health advisers endorsed a booster of Johnson & Johnson's Covid-19 vaccine, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands. J&J told the Food and Drug Administration that an extra dose adds important protection as early as two months after initial vaccination — but that it might work better if people wait until six months later.
0
shares
ShareTweetSavePostSend
 
Video Credit: WTVR - Scripps - Published
News video: FDA panel endorses lower-dose Moderna COVID shot for booster

FDA panel endorses lower-dose Moderna COVID shot for booster 01:11

A panel of U.S. health advisers has endorsed booster shots for Moderna’s COVID-19 vaccine. The advisers to the Food and Drug Administration voted Thursday to recommend a lower-dose booster shot for seniors and other high-risk groups.

You Might Like


Related videos from verified sources

Will young children need booster shot? [Video]

Will young children need booster shot?

The medical director of pediatric critical care at Palms West Hospital answered questions from WPTV viewers about COVID-19 vaccines for children.

Credit: WPTV News | West Palm Beach     Duration: 01:41Published
What will a COVID-19 vaccine for younger kids mean? An expert weighs in [Video]

What will a COVID-19 vaccine for younger kids mean? An expert weighs in

I am excited that the FDA panel recommended Pfizer’s vaccine for kids 5 to 11. As I’ve said before, I have two sons in this age group and I’m looking forward to when they can get vaccinated.

Credit: WXYZ Detroit     Duration: 03:18Published
Moderna, Johnson & Johnson COVID-19 booster shots available, Pima County says [Video]

Moderna, Johnson & Johnson COVID-19 booster shots available, Pima County says

Moderna and Johnson & Johnson COVID-19 booster shots are now available in Pima County.

Credit: KGUN, Tucson, AZ     Duration: 01:38Published

Related news from verified sources

FDA panel endorses lower-dose Moderna COVID shot for booster


Indian Express

US backs Pfizer's low-dose COVID-19 vaccine for kids, FDA approval expected soon

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine's benefits in preventing COVID-19 in that age group...
Zee News